{
    "id": "7875efff-59e3-4f68-84c5-e3c9c16d6a3c",
    "indications": "Zestril is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1.1 ) Adjunct therapy for heart failure ( 1.2 ) Treatment of Acute Myocardial Infarction ( 1.3 )",
    "contraindications": "Hypertension: Initial adult dose is 10 mg once daily. Titrate up to 40 mg daily based on blood pressure response. Initiate patients on diuretics at 5 mg once daily ( 2.1 ) Pediatric patients with glomerular filtration rate > 30 mL/min/1.73m 2 : Initial dose in patients 6 years of age and older is 0.07 mg per kg (up to 5 mg total) once daily ( 2.1 ) Heart Failure: Initiate with 5 mg once daily. Increase dose as tolerated to 40 mg daily ( 2.2 ) Acute Myocardial Infarction (MI): Give 5 mg within 24 hours of MI. Followed by 5 mg after 24 hours, then 10 mg once daily ( 2.3 ) Renal Impairment: For patients with creatinine clearance ≥ 10 mL/min and ≤ 30 mL/min, halve usual initial dose. For patients with creatinine clearance < 10 mL/min or on hemodialysis, the recommended initial dose is 2.5 mg ( 2.4 )",
    "warningsAndPrecautions": "Zestril is available as uncoated biconvex tablets in bottles of 90.\n                  \n                     \n                        \n                           Strength\n                           Color\n                           Shape\n                           Scored\n                           Side 1/Side 2\n                           NDC 24979-\n                           \n                        \n                        \n                           2.5 mg\n                           White\n                           Round\n                           No\n                           ZESTRIL 2½/135\n                           238-07\n                           \n                        \n                        \n                           5 mg\n                           Pink\n                           Capsule-Shaped\n                           Yes\n                           ZESTRIL/130\n                           239-07\n                           \n                        \n                        \n                           10 mg\n                           Pink\n                           Round\n                           No\n                           ZESTRIL 10/131\n                           240-07\n                           \n                        \n                        \n                           20 mg\n                           Pale Brownish Red\n                           Round\n                           No\n                           ZESTRIL 20/132\n                           241-07\n                           \n                        \n                        \n                           30 mg\n                           Pale Brownish Red\n                           Round\n                           No\n                           ZESTRIL 30/133\n                           242-07\n                           \n                        \n                        \n                           40 mg\n                           Yellow\n                           Round\n                           No\n                           ZESTRIL 40/134\n                           243-07\n                           \n                        \n                     \n                  \n                  Store at controlled room temperature, 20° to 25°C (68° to 77°F) [see USP].  Protect from moisture, freezing and excessive heat.  Dispense in a tight container.",
    "adverseReactions": "Zestril is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer Zestril within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor [\n                     see Warnings and Precautions (5.2)].\n                  Zestril is contraindicated in patients with:\n                  \n                     a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor\n                     hereditary or idiopathic angioedema\n                  \n                  Do not co-administer aliskiren with ZESTRIL in patients with diabetes [see\n                     \n                         Drug Interactions (7.4)\n                     \n                     ].",
    "ingredients": [
        {
            "name": "LISINOPRIL",
            "code": "E7199S1YWR"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "organization": "Upsher-Smith Laboratories, LLC",
    "name": "Zestril",
    "effectiveTime": "20250102"
}